Details of the Drug

General Information of Drug (ID: DMRI15Q)

• Drug Name: ACE-536

Indication

Disease Entry	ICD 11	Status	REF
Myelodysplastic syndrome	2A37	Phase 3	[1]
Anemia	3A00-3A9Z	Phase 2	[2]
Myelofibrosis	2A20.2	Phase 2	[1]

• Cross-matching ID: TTD ID: D07UQQ
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT02268409) ACE-536 Extension Study - Beta Thalassemia. U.S. National Institutes of Health.